It ‘s worth noting that back EMF plays a critical role as a natural current limiter during normal motor operation. When motor ...

Good day, ladies and gentlemen, and welcome to your Capstone Green Energy Earnings Conference Call and Webcast for the financial results for the second quarter fiscal year 2026 ended on September 30, ...

The integration of circular economy (CE) principles into petrochemical megaprojects is rapidly emerging as a strategic ...

Researchers from the Hong Kong University of Science and Technology (HKUST) and Tongji University have developed FerroAI, a ...

A secretive California startup just fired a machine so powerful it outpaces the energy draw of four megacities—at once. Built ...

This study shows that excitatory cholecystokinin (CCK)-expressing neurons in hippocampal area CA3 influence hippocampal-dependent memory using multiple methods to manipulate excitatory CCK-expressing ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

Move over, chatbots and image generators: This is the era of AI video generators. Don't miss any of our unbiased tech content and lab-based reviews. Add CNET as a preferred Google source. Many of ...

Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants. Minerva and the FDA have defined a path forward for roluperidone’s clinical ...